Copyright
        ©The Author(s) 2024.
    
    
        World J Diabetes. Jun 15, 2024; 15(6): 1226-1233
Published online Jun 15, 2024. doi: 10.4239/wjd.v15.i6.1226
Published online Jun 15, 2024. doi: 10.4239/wjd.v15.i6.1226
            Table 1 Comparison of patients’ general data
        
    | Research (n = 65) | Control (n = 60) | t/χ2 | P value | 95%CI | |
| Sex (male/female) | 39/26 | 40/20 | 0.5962 | 0.4400 | 0.3610 to 1.5580 | 
| Average age (yr) | 64.66 ± 5.45 | 66.63 ± 6.15 | 1.6132 | 0.1093 | -0.3856 to 3.8370 | 
| BMI (kg/m2) | 22.39 ± 1.75 | 22.91 ± 1.84 | 1.6193 | 0.7079 | -0.1081 to 1.1630 | 
| Course of diabetes mellitus (yr) | 10.58 ± 1.95 | 10.68 ± 2.74 | 0.2365 | 0.8135 | -1.1820 to 2.2130 | 
| NYHA grading of cardiac function | 125.03 | < 0.0001 | |||
| I | 0 | 60 | |||
| II | 19 | 0 | |||
| III | 25 | 0 | |||
| IV | 21 | 0 | |||
| History of hypertension | 30 | 25 | 0.2550 | 0.6136 | 0.5911 to 2.4360 | 
| Smoking history | 32 | 23 | 1.5041 | 0.2201 | 0.7651 to 3.181 | 
            Table 2 Neutrophil-lymphocyte ratio and red blood cell distribution width levels in two groups
        
    | NLR | RDW | LVEF (%) | |
| Research (n = 65) | 5.40 ± 1.79 | 16.00 ± 1.63 | 41.85 ± 7.23 | 
| Control (n = 60) | 2.99 ± 0.98 | 13.88 ± 1.08 | 58.07 ± 6.79 | 
| t | 9.2283 | 8.4976 | 12.9016 | 
| P value | < 0.0001 | < 0.0001 | < 0.0001 | 
| 95%CI | -2.921 to -1.889 | -2.619 to -1.629 | 13.73 to 18.71 | 
            Table 3 Comparison of general data in research groups with different cardiac function grades
        
    | NYHA classification | n | Male | Age (mean ± SD) | Course of diabetes mellitus | NLR | RDW | LEVF (%) | 
| II | 19 | 8 | 62.79 ± 4.83 | 10.77 ± 1.83 | 3.91 ± 1.64 | 14.72 ± 1.25 | 45.82 ± 6.14 | 
| III | 25 | 16 | 65.84 ± 5.81 | 10.30 ± 1.96 | 5.55 ± 1.31 | 15.53 ± 1.04 | 42.75 ± 5.94 | 
| IV | 21 | 15 | 65.71 ± 6.25 | 10.75 ± 2.11 | 6.56 ± 1.48 | 17.72 ± 0.93 | 37.20 ± 7.23 | 
| F | 3.8452 | 1.8600 | 0.4070 | 16.4300 | 42.7900 | 9.3240 | |
| P value | 0.1463 | 0.1643 | 0.6674 | < 0.0001 | < 0.0001 | 0.0003 | 
            Table 4 Diagnostic efficiency of neutrophil-lymphocyte ratio and red blood cell distribution width
        
    | AUC | SE | Specificity (%) | Sensitivity (%) | 95%CI | |
| NLR | 0.864 | 0.033 | 90.0 | 75.4 | 0.799-0.929 | 
| RDW | 0.859 | 0.034 | 86.7 | 76.9 | 0.793-0.925 | 
| Joint detection | 0.915 | 0.027 | 100.0 | 76.9 | 0.863-0.968 | 
            Table 5 Comparison of neutrophil-lymphocyte ratio and red blood cell distribution width levels in patients with or without cardiac events
        
    | n | NLR | RDW | |
| Without cardiac events | 46 | 4.97 ± 1.66 | 15.70 ± 1.64 | 
| With cardiac events | 19 | 6.45 ± .68 | 16.72 ± 1.42 | 
| t | 3.2610 | 2.3540 | |
| P value | 0.0018 | 0.0217 | 
- Citation: Pang J, Qian LY, Lv P, Che XR. Application of neutrophil-lymphocyte ratio and red blood cell distribution width in diabetes mellitus complicated with heart failure. World J Diabetes 2024; 15(6): 1226-1233
 - URL: https://www.wjgnet.com/1948-9358/full/v15/i6/1226.htm
 - DOI: https://dx.doi.org/10.4239/wjd.v15.i6.1226
 
